Kevin Coker Jd, Mph

Kevin Coker, JD, MPH, MS has a diverse work experience in the healthcare and life science industry. Kevin co-founded and served as CEO of Proxima Clinical Research, Inc., a Contract Research Organization that specializes in assisting life science companies with the development of drugs, devices, diagnostics, and digital therapeutics. Kevin also founded M1 MedTech and currently serves as the principal of the company. In addition, they host the Inventing Tomorrow Podcast and is a member of the Forbes Business Council. Kevin has provided advisory services to companies such as Bioverge and First Bight Ventures. Kevin has also served as a board member for Volumetric, Inc. Kevin has held leadership positions at MolecularMatch, Worldwide Clinical Trials, Inc., and McKesson, where they were responsible for research services and global franchise lead. Overall, Kevin Coker's work experience demonstrates their expertise in the healthcare and life science industry.

Kevin Coker, JD, MPH, MS has an extensive education history. Kevin earned a Bachelor of Science (B.S.) degree in Biology from the University of Central Arkansas. Kevin then pursued further studies at the University of Arkansas for Medical Sciences, where they completed a Master of Science (MS) degree in Pathology. However, their education at this institution also included doctoral studies in the field of Philosophy (PhD), which they did not complete, accumulating 30 hours of study.

Kevin's pursuit of higher education continued at Case Western Reserve University, where they earned a Doctor of Law (JD) degree from the School of Law. Additionally, they obtained a Master of Public Health (MPH) degree from the School of Medicine.

In addition to their formal education, Kevin Coker holds several certifications. Kevin is certified as a Clinical Molecular Biology Lab Specialist (CLSp(MB)) by the National Credentialing Agency. Kevin is also a member of the Bar, as recognized by the Arkansas Supreme Court. Furthermore, they hold a certification in Pharmaceutical Regulatory Affairs (RAC) from the Regulatory Affairs Professionals Society (RAPS).